Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids

mRNA analysis and promoter characterization

Authors

  • Conception Paul,

    1. 1 INSERM U-376, Hôpital Arnaud de Villeneuve, Montpellier, France; 2 Nutrition and Diabetes Unit, School of Medicine,
      The University of Louvain, Brussels, Belgium
    Search for more papers by this author
  • 1 Iban Seiliez,

    1. 1 INSERM U-376, Hôpital Arnaud de Villeneuve, Montpellier, France; 2 Nutrition and Diabetes Unit, School of Medicine,
      The University of Louvain, Brussels, Belgium
    Search for more papers by this author
  • 1 Jean P. Thissen,

    1. 1 INSERM U-376, Hôpital Arnaud de Villeneuve, Montpellier, France; 2 Nutrition and Diabetes Unit, School of Medicine,
      The University of Louvain, Brussels, Belgium
    Search for more papers by this author
  • and 2 Alphonse Le Cam 1

    1. 1 INSERM U-376, Hôpital Arnaud de Villeneuve, Montpellier, France; 2 Nutrition and Diabetes Unit, School of Medicine,
      The University of Louvain, Brussels, Belgium
    Search for more papers by this author

A. Le Cam, INSERM Unité 376, 371 rue du doyen Gaston Giraud, Hôpital Arnaud de Villeneuve, F-34295 Montpellier cedex 05, France. Fax: + 33 67 41 52 22, Tel.: + 33 67 41 52 27, E-mail: lecam@u376.montp.inserm.fr.

Abstract

Suppressors of cytokine signalling (SOCS) represent a newly discovered family of molecules that seem to play an important role in the shutting off of cytokine and possibly peptide hormone action. Thus, understanding the mechanisms controlling their expression is of cardinal importance. In the present study, we have cloned the rat SOCS-3 gene and analyzed its expression and the functioning of its promoter in hepatocytes. Expression of SOCS-3 mRNA, which is very weak in freshly isolated cells, tended to increase when hepatocytes were incubated without hormones. Growth hormone (GH) and, to a much larger extent, interleukin-6 (IL-6) rapidly activated mRNA synthesis whereas glucocorticoids (GC) strongly inhibited both basal and hormone-dependent expressions. A short promoter fragment (−137/+35) responded maximally to GH and IL-6 (a threefold stimulation for each effector) and to GC (a 70–80% inhibition), whereas longer promoter sequences supported higher basal activity and lower positive hormonal responses. Deletion and mutation analyses indicated that all hormonal responses were dependent on two cis-acting sequences termed the G-rich and the A/T-rich elements. Only the A/T-rich element was active in a heterologous context, thus behaving as a typical enhancer. Unexpectedly, the two signal transducer and activator of transcription (STAT) binding sites found immediately upstream of the G-rich motif didn’t seem to participate in either GH or IL-6 effect, despite the fact that one of them strongly responded to IL-6 when placed in front of a heterologous promoter. Finally, the negative regulation of SOCS-3 promoter by GC that may contribute to gene silencing in vivo, appeared to involve interactions of the GC receptor with other transcription factors and not direct binding to DNA, as no GC-response element was found in the sequence.

Ancillary